Pressroom

USC research finds that the answer to getting more shots into arms is just a text message or email away.

Published in JAMA, the findings from USC and University of Wisconsin–Madison researchers suggest the policy cut the number of Medicare enrollees who weren’t filling insulin because of cost.

For the first time in two decades, an Alzheimer’s drug has received full Food and Drug Administration (FDA) approval. USC Schaeffer Center experts are available to discuss this milestone and the challenges ahead.

Overpayments to Medicare Advantage plans now exceed 20% annually, underscoring the urgent need for reform.

Researchers found that behavioral interventions aimed at improving performance can be designed to protect clinician job satisfaction and improve quality of care.

Researchers looked at cancer therapy trastuzumab (Herceptin) and found biosimilars bring competition to the market, with prices declining by more than half for some versions.

The first study to examine biosimilar drivers finds commercial insurers limit use in almost 20% of cases.

Darius Lakdawalla was part of a panel of experts called upon by the U.S. House Ways and Means Subcommittee on Health.

USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.

The researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.